Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production()

Por Thompson, Afton L., Johnson, Brandi T., Sempowski, Gregory D., Gunn, Michael D., Hou, Baidong, DeFranco, Anthony L., Staats, Herman F.
Publicado em 2012

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen

Por Gwinn, William M., Johnson, Brandi T., Kirwan, Shaun M., Sobel, Ashley E., Abraham, Soman N., Gunn, Michael D., Staats, Herman F.
Publicado em 2013

Premature T Cell Senescence in Pediatric CKD

Por George, Roshan P., Mehta, Aneesh K., Perez, Sebastian D., Winterberg, Pamela, Cheeseman, Jennifer, Johnson, Brandi, Kwun, Jean, Monday, Stephanie, Stempora, Linda, Warshaw, Barry, Kirk, Allan D.
Publicado no J Am Soc Nephrol (2017)

LFA-1–specific therapy prolongs allograft survival in rhesus macaques

Por Badell, Idelberto R., Russell, Maria C., Thompson, Peter W., Turner, Alexandra P., Weaver, Tim A., Robertson, Jennifer M., Avila, Jose G., Cano, Jose A., Johnson, Brandi E., Song, Mingqing, Leopardi, Frank V., Swygert, Sarah, Strobert, Elizabeth A., Ford, Mandy L., Kirk, Allan D., Larsen, Christian P.
Publicado em 2010